These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Infectivity of urogenital Chlamydia trachomatis plasmid-deficient, CT135-null, and double-deficient strains in female mice. Sturdevant GL; Zhou B; Carlson JH; Whitmire WM; Song L; Caldwell HD Pathog Dis; 2014 Jun; 71(1):90-2. PubMed ID: 24376189 [TBL] [Abstract][Full Text] [Related]
3. Genetic Screen in Chlamydia muridarum Reveals Role for an Interferon-Induced Host Cell Death Program in Antimicrobial Inclusion Rupture. Giebel AM; Hu S; Rajaram K; Finethy R; Toh E; Brothwell JA; Morrison SG; Suchland RJ; Stein BD; Coers J; Morrison RP; Nelson DE mBio; 2019 Apr; 10(2):. PubMed ID: 30967464 [TBL] [Abstract][Full Text] [Related]
4. The Chlamydia trachomatis Plasmid and CT135 Virulence Factors Are Not Essential for Genital Tract Infection or Pathology in Female Pig-Tailed Macaques. Patton DL; Sweeney YC; Baldessari AE; Cles L; Kari L; Sturdevant GL; Yang C; Caldwell HD Infect Immun; 2018 May; 86(5):. PubMed ID: 29463617 [TBL] [Abstract][Full Text] [Related]
5. Chlamydia trachomatis Is Resistant to Inclusion Ubiquitination and Associated Host Defense in Gamma Interferon-Primed Human Epithelial Cells. Haldar AK; Piro AS; Finethy R; Espenschied ST; Brown HE; Giebel AM; Frickel EM; Nelson DE; Coers J mBio; 2016 Dec; 7(6):. PubMed ID: 27965446 [TBL] [Abstract][Full Text] [Related]
6. Chlamydia trachomatis virulence factor CT135 is stable in vivo but highly polymorphic in vitro. Bonner C; Caldwell HD; Carlson JH; Graham MR; Kari L; Sturdevant GL; Tyler S; Zetner A; McClarty G Pathog Dis; 2015 Aug; 73(6):ftv043. PubMed ID: 26109550 [TBL] [Abstract][Full Text] [Related]
7. Chlamydia trachomatis In Vivo to In Vitro Transition Reveals Mechanisms of Phase Variation and Down-Regulation of Virulence Factors. Borges V; Pinheiro M; Antelo M; Sampaio DA; Vieira L; Ferreira R; Nunes A; Almeida F; Mota LJ; Borrego MJ; Gomes JP PLoS One; 2015; 10(7):e0133420. PubMed ID: 26207372 [TBL] [Abstract][Full Text] [Related]
8. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Sturdevant GL; Kari L; Gardner DJ; Olivares-Zavaleta N; Randall LB; Whitmire WM; Carlson JH; Goheen MM; Selleck EM; Martens C; Caldwell HD Infect Immun; 2010 Sep; 78(9):3660-8. PubMed ID: 20547745 [TBL] [Abstract][Full Text] [Related]
9. Sensing the enemy, containing the threat: cell-autonomous immunity to Chlamydia trachomatis. Finethy R; Coers J FEMS Microbiol Rev; 2016 Nov; 40(6):875-893. PubMed ID: 28201690 [TBL] [Abstract][Full Text] [Related]
11. Stromal Fibroblasts Drive Host Inflammatory Responses That Are Dependent on Chlamydia trachomatis Strain Type and Likely Influence Disease Outcomes. Jolly AL; Rau S; Chadha AK; Abdulraheem EA; Dean D mBio; 2019 Mar; 10(2):. PubMed ID: 30890604 [No Abstract] [Full Text] [Related]
12. Innate Lymphoid Cells Are Required for Endometrial Resistance to Xu H; Su X; Zhao Y; Tang L; Chen J; Zhong G Infect Immun; 2020 Jun; 88(7):. PubMed ID: 32341118 [TBL] [Abstract][Full Text] [Related]
13. Chlamydia trachomatis Lipopolysaccharide Evades the Canonical and Noncanonical Inflammatory Pathways To Subvert Innate Immunity. Yang C; Briones M; Chiou J; Lei L; Patton MJ; Ma L; McClarty G; Caldwell HD mBio; 2019 Apr; 10(2):. PubMed ID: 31015326 [No Abstract] [Full Text] [Related]
14. High expression of IDO1 and TGF-β1 during recurrence and post infection clearance with Chlamydia trachomatis, are independent of host IFN-γ response. Ziklo N; Huston WM; Taing K; Timms P BMC Infect Dis; 2019 Mar; 19(1):218. PubMed ID: 30832593 [TBL] [Abstract][Full Text] [Related]
15. Chlamydia trachomatis Plasmid Gene Protein 3 Is Essential for the Establishment of Persistent Infection and Associated Immunopathology. Yang C; Kari L; Lei L; Carlson JH; Ma L; Couch CE; Whitmire WM; Bock K; Moore I; Bonner C; McClarty G; Caldwell HD mBio; 2020 Aug; 11(4):. PubMed ID: 32817110 [No Abstract] [Full Text] [Related]
16. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-gamma-mediated inhibition. Perry LL; Su H; Feilzer K; Messer R; Hughes S; Whitmire W; Caldwell HD J Immunol; 1999 Mar; 162(6):3541-8. PubMed ID: 10092812 [TBL] [Abstract][Full Text] [Related]
17. Intravaginal Chlamydia trachomatis Challenge Infection Elicits TH1 and TH17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage. Vicetti Miguel RD; Quispe Calla NE; Pavelko SD; Cherpes TL PLoS One; 2016; 11(9):e0162445. PubMed ID: 27606424 [TBL] [Abstract][Full Text] [Related]
18. The Herrera CM; McMahon E; Swaney DL; Sherry J; Pha K; Adams-Boone K; Johnson JR; Krogan NJ; Stevers M; Solomon D; Elwell C; Engel J Microbiol Spectr; 2024 Jul; 12(7):e0045324. PubMed ID: 38814079 [No Abstract] [Full Text] [Related]
19. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Johansson M; Schön K; Ward M; Lycke N Infect Immun; 1997 Mar; 65(3):1032-44. PubMed ID: 9038313 [TBL] [Abstract][Full Text] [Related]